Dr. Dhruv Khullar

speaker

279 appearances 1 recordings 1 series first heard Jun 2026 last heard 23 Jun

Dr. Dhruv Khullar’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Jun 2026 with 1.

Appearances

newest first · ▶ plays the moment

On the Mind with Dr. Daniel Knoepflmacher · On AI and Mental Health: It's Already Here. Are We Ready? · 23 Jun 2026 podcast

company.

I think i i it's not that necessarily all these types of companies are

bad or that they're not fulfilling a need that actually needs to be met.

But where things can go awry is when the business model is pointing you in one direction and the care for the patient is pointing you in a different direction.

So that's the first thing that I would say is that we need to understand what the incentives are.

And that's true of AI companies and that's true of other companies as well.

The other thing that I think would be really helpful is just trying to help people understand the distinctions between levels of evidence when recommendations or products are being proffered.

And so it is not to say that every product on the market is going to have a double blinded placebo-controlled randomized controlled trial.

And that's fine.

But there's a huge difference between something has interesting animal studies, something has particular theoretical reasons.

reasons that it might work.

We have lots of anecdotes.

We have some observational studies.

We have other types of evidence that we I think that this might help or work.

But helping people understand the level of evidence behind a particular recommendation, a particular product, I think that can potentially go a long way as well.

And the level of evidence that we require depends on how risky the intervention is.

And so if someone's telling you to, let's say, drink more water or take time to exercise more or something like this, those are not particularly risky interventions.

And so we might look at them differently than someone telling you to take this peptide or pay take this supplement.

I think the first thing I would say is that we should really emphasize that we want to generate a strong evidence base behind AI-driven interventions.

And so to the extent that claims are being made and things are being piloted in hospitals and clinics, there should be some type of evidence that's collected on them and then presented in the way that we've done for a long time.

Showing 241–260 of 279 · page 13 of 14